Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Rhabdoid Tumor 1Neuroectodermal Tumors, Primitive 1Medulloblastoma 1Leukemia, Myeloid, Acute 1Glioma 1Ependymoma 1Choroid Plexus Carcinoma 1Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 3Temozolomide 2thymoglobulin 1gallium Ga 68 dotatate 1fludarabine phosphate 1Thiotepa 1Tacrolimus 1Stem Cell Transplantation 1Radiotherapy 1Nivolumab 1Mycophenolic Acid 1Methotrexate 1Melphalan 1Hematopoietic Stem Cell Transplantation 1Gadolinium DTPA 1Etoposide 1Erlotinib Hydrochloride 1Biopsy 1Bandages 1Azacitidine 1Antilymphocyte Serum 12-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Ependymoma × Hematopoietic Stem Cell Transplantation × Clear all
NCT04521946 2024-10-26

Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer

M.D. Anderson Cancer Center

Phase 1 Withdrawn
CNS

Choroid Plexus Carcinoma, Brain Neoplasms, Ependymoma, Glioma, Medulloblastoma, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡